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Abstract
Fragile X syndrome (FXS), the most common form of inherited mental retardation, is caused by the loss of functional fragile
X mental retardation protein (FMRP). FMRP is an RNA–binding protein that can regulate the translation of specific mRNAs.
Adult neurogenesis, a process considered important for neuroplasticity and memory, is regulated at multiple molecular
levels. In this study, we investigated whether Fmrp deficiency affects adult neurogenesis. We show that in a mouse model of
fragile X syndrome, adult neurogenesis is indeed altered. The loss of Fmrp increases the proliferation and alters the fate
specification of adult neural progenitor/stem cells (aNPCs). We demonstrate that Fmrp regulates the protein expression of
several components critical for aNPC function, including CDK4 and GSK3b. Dysregulation of GSK3b led to reduced Wnt
signaling pathway activity, which altered the expression of neurogenin1 and the fate specification of aNPCs. These data
unveil a novel regulatory role for Fmrp and translational regulation in adult neurogenesis.
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Introduction
Fragile X syndrome, one of the most common forms of inherited
mental retardation, is caused by the functional loss of fragile X
mental retardation protein (FMRP/Fmrp) [1]. Patients with fragile
X syndrome show an array of deficits in motor control, cognition,
learning, and memory, although their overall brain morphology is
generally normal. Fmrp is a selective RNA-binding protein that
forms a messenger ribonucleoprotein (mRNP) complex that can
associate with polyribosomes. Evidence suggests that Fmrp is
involved in the post-transcriptional regulation of protein synthesis
[2–4]. Studies from both human patient brain tissues and Fmrp
mutant mice suggest that Fmrp is involved in synaptic plasticity
and dendritic development. Fmrp mutant mice are found to
perform poorly in highly challenging learning tests [5], particularly
the hippocampus-dependent trace learning test [6,7], suggesting
that Fmrp is necessary especially for complex learning that requires
an intact hippocampus. However, how the functional deficiency of
Fmrp results in learning and memory deficits remains unclear.
Neurogenesis persists throughout life in two germinal zones, the
subgranular zone (SGZ) in the dentate gyrus (DG) of the
hippocampus and the subventricular zone (SVZ) of the lateral
ventricles. The neurons produced in the DG during adulthood are
known to integrate into the existing circuitry of the hippocampus,
and young neurons show greater synaptic plasticity than mature
neurons under identical conditions [8,9]. Although the specific
purpose of adult neurogenesis is still being debated, mounting
evidence points to an important role in adult neuroplasticity
[9–11]. It has been suggested that new neurons in the DG are
critical for hippocampus-dependent learning [10,12,13]. Indeed,
blocking of adult neurogenesis using generic anti-proliferative
drugs or radiation can lead to deficits in learning and memory
[14–16]. More recent direct evidence has come from inducing the
death of new neurons in the hippocampus [17–19] and from
inhibiting the Wnt signaling pathway in the hippocampus using
retrovirus [20]. Adult neurogenesis is regulated at many levels by
both extrinsic factors, such as physiological and pathological
conditions, and intrinsic factors, such as genetic and epigenetic
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and learning are altered in several pathological conditions, such as
stress, diabetes, neurological diseases, strokes, and traumatic
injuries, the link between adult neurogenesis and mental
retardation, a deficiency in learning and memory, remains elusive
[9–11].
The cellular basis of adult neurogenesis is adult neural
progenitor/stem cells (aNPCs). The maintenance and differen-
tiation of aNPCs are tightly controlled by intricate molecular
networks [22]. Despite exhaustive efforts devoted to under-
standing transcriptional regulation in adult neurogenesis, the
role of translational control by RNA-binding proteins, such as
Fmrp, has gone largely unexplored. Recently, Fmrp was found
to be required for the maintenance of Drosophila germline stem
cells [23]; however, its function in mammalian embryonic
neurogenesis is controversial [24,25]. Whether and how Fmrp
regulates neural stem cells in the adult mammalian brain and
the implications for learning and memory have not been
established.
Here we show that loss of Fmrp in vitro and in vivo led to altered
adult neurogenesis and impaired learning. Fmrp-deficient aNPCs
displayed increased proliferation and decreased neuronal differ-
entiation, but increased glial differentiation. We identified specific
mRNAs regulated by Fmrp in stem cell proliferation and
differentiation, including glycogen synthase kinase 3b (GSK3ß),
a negative regulator of ß-catenin and the canonical Wnt signaling
pathway that has been implicated in adult neurogenesis [26,27].
The loss of Fmrp resulted in reduced ß-catenin levels and a
defective Wnt signaling pathway, which in turn led to the
downregulation of neurogenin1 (Neurog1), which is an early
initiator of neuronal differentiation and an inhibitor of astrocyte
differentiation [28,29]. These data not only reveal a novel
regulatory role for Fmrp in adult neurogenesis, but also provide
direct evidence that adult neurogenesis could be a factor in the
pathogenesis of fragile X mental retardation.
Results
Loss of Fmrp alters the proliferation and fate
specification of aNPCs
To investigate the role of Fmrp in adult neurogenesis, we
determined the expression pattern of Fmrp in the dentate gyrus
(DG) of the adult hippocampus using cell type-specific markers.
Consistent with published literature [30,31], Fmrp was enriched in
a majority of the granule neurons in the DG (Figure S1A), but was
undetectable in either GFAP-positive or S100b-positive astrocytes
(Figure S1B and S1C). Using markers specific to immature neural
progenitors (NPCs) and young neurons, we discovered that Fmrp
was also expressed in Sox2 and Nestin double-positive NPCs
(Figure 1A), as well as in either NeuroD1-postive or doublecortin
(DCX)-positive newly generated neurons (Figure 1B and 1C). The
presence of Fmrp in these immature cells supports a potential
function of this protein in adult neurogenesis.
To determine the functions of Fmrp in aNPCs, we isolated
aNPCs from both the forebrain and the dentate gyrus (DG) of
adult Fmr1 knockout (KO) mice and wild-type (WT) controls. Due
to the difficulty of obtaining large numbers of the DG aNPCs, we
performed all functional assays first using forebrain aNPCs, and
then confirmed our findings using the DG aNPCs. As shown
below, we found that both the forebrain aNPCs and the DG
aNPCs yielded similar results. Nearly all cultured aNPCs were
positive for the progenitor markers Nestin and Sox2 (Figure 1D),
suggesting a relative homogeneity of these primary aNPCs. Fmrp
was expressed in WT aNPCs, but not in Fmr1 KO aNPCs
(Figure 1E). We pulsed the cells with BrdU for eight hours to assess
Figure 1. Fmrp is expressed in aNPCs and new neurons in the
adult DG, and the loss of Fmrp leads to increased aNPC
proliferation. (A) Fmrp is expressed in Sox2 (white) and Nestin (green)
double-positive NPCs (arrowheads) in the granule neurons of the adult
hippocampus. Arrowhead points to a positive cell located at the
subgranular zone adjacent to the hilar region. (B,C) Fmrp is expressed in
doublecortin (DCX)-positive (B, green) and NeuroD1-postive (C, green)
newly generated neurons. Asterisks identify positive cells located at the
subgranular zone adjacent to the hilar region. (A–C, Fmrp, red; Dapi,
blue; Scale bars=10 mm;). (D) aNPCs cultured under proliferating
conditions expressed the neural progenitor markers Nestin (cytoplasmic,
red) and Sox2 (nuclear, green; Dapi in blue). (E) Proliferating WT aNPCs,
but not Fmr1 KO aNPCs, expressed Fmrp. (F) Both WT and KO aNPCs
incorporate the thymidine analog, BrdU, under proliferating conditions
(BrdU, red; Dapi, blue; (D,F), Scale bars=50 mm). (G) Quantitative
analysis showing that a higher percentage of Fmr1 KO aNPCs
incorporated BrdU. (*, p,0.05; n=3; Student’s t-test; mean 6 SEM).
doi:10.1371/journal.pgen.1000898.g001
Author Summary
Fragile X syndrome, the most common cause of inherited
mental retardation, results from the loss of functional
Fragile X mental retardation protein (FMRP). FMRP is an
RNA–binding protein and is known to bind to specific
mRNAs and to regulate their translation both in vitro and
in vivo. Adult neurogenesis, a process considered impor-
tant for neuroplasticity and memory, is regulated at
multiple molecular levels. Here we show that Fmrp could
regulate the proliferation and fate specification of adult
neural progenitor/stem cells (aNPCs). These data unveil a
novel regulatory role for Fmrp in adult neurogenesis.
FMRP in Adult Neurogenesis
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KO aNPCs exhibited twice as much BrdU incorporation as WT
aNPCs (Figure 1G). We further analyzed the cell cycle profiles of
aNPCs and found that more Fmr1 KO cells were in mitotic (G2/
M) phase compared with WT controls (Figure S2, 11% higher;
n=3, p,0.02). Hence a lack of functional Fmrp led to a rise in the
proliferative capability of aNPCs.
To assess the effect of Fmrp on aNPC differentiation, both WT
and Fmr1 KO forebrain aNPCs were differentiated for three days,
and the phenotypes of differentiated cells were determined using
several independent assays. First, differentiated cells were stained
using cell lineage-specific antibodies, b-III tubulin (Tuj1) for
neurons and glial fibrillary acidic protein (GFAP) for astroglia
[32,33]. Both WT and Fmr1 KO aNPCs could be induced to
differentiate into neurons and astrocytes (Figure 2A and 2B);
however, Fmr1 KO aNPCs exhibited a 60.4% decrease in
neuronal differentiation (Figure 2C) and a 74.9% increase in
astrocyte differentiation (Figure 2D) compared with WT aNPCs.
Under our culture conditions, only differentiated astrocytes, not
proliferating aNPCs, expressed GFAP (data not shown). To
validate our immunocytochemical data, we then assessed the
neuronal differentiation of aNPCs by measuring the promoter
activity of a pan-neuronal transcription factor, neurogenic
differentiation 1 (NeuroD1), and astrocyte differentiation by
measuring the promoter activity of GFAP using two well-
characterized promoter constructs [34–37]. We found that in
Fmr1 KO aNPCs, NeuroD1 promoter activity decreased by 31.4%
(Figure 2E), whereas GFAP promoter activity increased by 73.4%
(Figure 2F), which is consistent with our immunocytochemistry
results. Finally, using real-time quantitative PCR, we further
demonstrated that differentiating Fmr1 KO aNPCs had 17.8%
reduced NeuroD1 mRNA (Figure 2G, n=3, p,0.05), but 1.56-fold
increased GFAP mRNA (Figure 2H; n=3, p,0.05) levels. Since
the above three methods, immunostaining, promoter activity
assay, and real-time PCR, yielded consistent results, we used these
assays as interchangeable methods for assessing aNPC differenti-
ation in subsequent experiments. The increased proportion of
astrocytes in differentiating Fmr1 KO aNPCs was not due to an
increased proliferation of newly differentiated astrocytes, because
GFAP
+ astrocytes differentiated from Fmr1 KO aNPCs did not
incorporate more BrdU compared with those from WT aNPCs
(data not shown). The differentiation to oligodendrocytes was no
different between Fmr1 KO and WT aNPCs (data not shown).
To confirm that the altered fate specification of Fmr1 KO
aNPCs was due to the loss of functional Fmrp, we used siRNA
(Fmr1-siRNA, Figure S3) to knock down Fmrp expression in WT
aNPCs. We found that acute knockdown of Fmrp expression in
WT aNPCs led to both reduced NeuroD1 (Figure 2I, left, n=4,
p,0.05) and Tuj1 (Figure 2I, middle, n=4, p,0.001) mRNA
levels, as well as diminished NeuroD1 promoter activity
(Figure 2I, right, n=6, p,0.05) compared with aNPCs
transfected with a nonsilencing control siRNA (NC-siRNA).
On the other hand, acute knockdown of Fmrp resulted in
increased mRNA levels of both GFAP (Figure 2J, left; n=4
p,0.01) and another astrocyte marker aquaporin4 [38,39]
(Figure 2J, middle, n=4, p,0.001), as well as enhanced GFAP
promoter activity (Figure 2J, right, n=6, p,0.05). Furthermore,
exogenously expressed WT Fmrp, but not mutant (I304N)
Fmrp, which is unable to bind polyribosomes [40], rescued both
the neuronal (Figure 2K) and the astrocyte (Figure 2L)
differentiation deficits associated with Fmr1 KO cells.
We then confirmed that aNPCs isolated from Fmr1 KO DG had
similar reductions in neuronal differentiation and increases in
astrocyte differentiation (Figure S4A, S4B, S4C, S4D) as Fmr1 KO
aNPCs derived from forebrain. In addition, acute knockdown of
Fmrp in the WT DG aNPCs resulted in phenotypes in neuronal
and astrocyte differentiation (Figure S4E, S4F, S4G, S4H) similar
to those we observed in forebrain aNPCs. Together, these results
suggest that the loss of Fmrp alters both the proliferation and fate
specification of aNPCs.
Loss of Fmrp alters adult neurogenesis in vivo
To investigate the role of Fmrp in adult neurogenesis in vivo,w e
assessed the proliferation, survival, and differentiation of endog-
enous aNPCs in both WT and Fmr1 KO mice. Newborn cells were
distinguished by the incorporation of BrdU administered through
intraperitoneal injections into adult mice using two cohorts of mice
(Figure 3A). Cohort 1 animals (Figure 3C) had the same injection
paradigm as those mice used for the differentiation assay (Figure 4);
therefore, they were used to assess new cell survival. Cohort 2
animals were used to evaluate cell proliferation in the DG.
Quantitative histological analysis at one day following a seven-day
regimen of daily BrdU injection (Cohort 1) showed that Fmr1 KO
mice had 52.0% more BrdU-positive cells compared with WT
mice (Figure 3C). To further assess the proliferation of aNPCs
without the confound of cell survival in Fmr1 KO mice, we gave
mice six doses of BrdU injection within 24 hours to label the entire
proliferating population in the DG based on a published paradigm
[41] and analyzed the mice at four hours after the last BrdU
injection (Figure 3D, Cohort 2). We found that Fmr1 KO mice had
53.2% more BrdU-positive cells compared with WT mice
(Figure 3D, p,0.001). Since the volume of the DG is also
increased in Fmr1 KO mice (Figure 3E, p,0.05) and the above
data were normalized to the DG volume, the total number of
BrdU-positive cells was even higher in KO mice compared with
WT controls. It has been shown that the adult DG contains at least
two types of proliferating immature cells that can be labeled by
BrdU: one type is GFAP+ and Nestin+ (Figure 3F lower panel)
and might be stem cells, whereas the other type is GFAP2 and
Nestin+ (Figure 3F upper panel) and more likely to be progenitor
cells [10,42]. To determine which types of cells exhibited increased
BrdU incorporation in Fmr1 KO mice, we stained the brain
sections with antibodies against BrdU, GFAP, and Nestin
(Figure 3F). We found that the Fmr1 KO DG had increased
BrdU incorporation in both the Nestin+/GFAP2 cell population
(Figure 3G, 40.8% increase, p,0.05) and the Nestin+/GFAP+ cell
population (Figure 3H, p,0.001, 1.2-fold increase). The prolifer-
ation of astrocytes (BrdU+, GFAP+, Nestin2 cells) was no
different between WT and Fmr1 KO mice (data not shown). Cell
proliferation in the SVZ was also 1.1-fold higher in Fmr1 KO mice
(p,0.05). Thus Fmrp deficiency may lead to increased prolifer-
ation of both stem and progenitor cells.
The long-term survival and differentiation of BrdU-labeled cells
was evaluated by analyzing the labeled cells at four weeks after
BrdU injections (Figure 4A–4C). The number of BrdU
+ cells at
four weeks post-injection was no different between WT and Fmr1
KO mice (Figure 4D); therefore, the percentage of BrdU
+ cells
that survived from one day to four weeks post-BrdU administra-
tion is significantly lower in Fmr1 KO mice compared with WT
mice (Figure 4E, p,0.05). Hence Fmrp deficiency may also lead to
reduced survival of young neurons.
Since we observed altered neuronal and astrocyte differen-
tiation of Fmr1 KO aNPCs in vitro (Figure 2), we then used
triple fluorescence immunostaining with antibodies for mature
neurons (NeuN) and astrocytes (S100b) to further determine
t h ef a t eo fd i f f e r e n t i a t e da N P C sin vivo (Figure 4B and 4C).
Consistent with our in vitro observation, we found that in Fmr1
KO mice, the percentage of BrdU
+ cells that are NeuN
+
FMRP in Adult Neurogenesis
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percentage of BrdU-positive cells that are S100b
+ astrocytes
was 75.7% higher compared with WT mice (Figure 4G,
p,0.05). In addition, the expression levels of NeuroD1 and
Neurog1, two transcription factors expressed in new neurons,
were also reduced in the hippocampus of Fmr1 KO mice
(Figure S5, n=3, p,0.05). Therefore, the loss of Fmrp leads to
reduced neuronal differentiation but greater glial differentia-
tion in aNPCs residing in the DG. These in vivo data along with
our in vitro results suggest that Fmrp indeed plays important
Figure 2. Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. (A,B) Sample
immunostained cells using cell lineage markers for quantitative cell fate determination shown in (C,D). Both WT (A) and Fmr1 KO (B) aNPCs could
differentiate into Tuj1
+ (red) neurons and GFAP
+ (green) astrocytes. (Scale bar=50 mm; DAPI, nuclear staining, blue). (C,D) Quantitative analyses of
differentiated aNPCs demonstrate that Fmr1 KO aNPCs differentiated into fewer Tuj1+ neurons (C, n=4; p,0.01) but more GFAP+ astrocytes (D, n=6,
p,0.05). Quantification was performed using an unbiased stereology method. (E,F), Luciferase reporter assay showing that differentiating Fmr1 KO
aNPCs had decreased NeuroD1 (E; n=4, p,0.01), but increased GFAP (F, n=3, p,0.05) promoter activities compared with WT aNPCs. A co-
transfected Renilla luciferase (R-Luc) plasmid was used as a transfection control. (G,H), Real-time PCR assays showing that Fmr1 KO aNPCs had
decreased NeuroD1 mRNA levels (G; n=3, p,0.05), but increased GFAP mRNA levels (H, n=3, p,0.05) upon differentiation. The relative mRNA levels
were in comparison with GAPDH mRNA. (I,J), Acute knockdown of Fmrp expression in WT aNPCs using siRNA led to decreased neuronal
differentiation (I; left NeuroD1; middle, Tuj1; right, NeuroD1-promoter), but increased astrocyte differentiation (J; left GFAP; middle, aquaporin4; right,
GFAP-promoter); (K,L), Exogenously expressed WT Fmrp, but not mutant (I304N) Fmrp, could enhance neuronal differentiation (K) and repress
astrocyte differentiation (L) in Fmr1 KO aNPCs. GAPDH mRNA levels were used as internal controls for real-time PCR analyses. Data are presented as
mean 6 SEM; *, p,0.05, **, p,0.01, ***, p,0.01, Student’s t-test.
doi:10.1371/journal.pgen.1000898.g002
FMRP in Adult Neurogenesis
PLoS Genetics | www.plosgenetics.org 4 April 2010 | Volume 6 | Issue 4 | e1000898roles in regulating the differentiation and proliferation of
aNPCs.
Fmrp regulates the mRNAs of critical factors involved in
aNPC proliferation and differentiation
As an RNA-binding protein, Fmrp is known to bind to a
subset of specific mRNAs and suppress their translation [43].
To identify the mRNAs that are regulated by Fmrp in aNPCs,
we employed the strategy of specifically immunoprecipitating
Fmrp-containing mRNP particles and identifying the copur-
ified mRNAs by probing expression microarrays, which we
established previously [44]. Due to the large quantity of
cells needed, we only used forebrain aNPCs derived from WT
and Fmr1 KO mice for immunoprecipitation with an antibody
that could specifically precipitate Fmrp (Figure 5A). Both
immunoprecipitated and input RNAs were used to probe
Affymetrix arrays (data not shown). The mRNAs of interest
were further confirmed to be associated with Fmrp by
independent IP and real-time PCR (Figure 5B). Among these
mRNAs, we found several already known to be regulated
by Fmrp, such as MAP1B [2] and EF1a [3], confirming the
specificity of our assay (Figure 5B and 5C). Also among the
identified mRNAs, we found two key factors well established as
enhancers of cell cycle progression, cyclin-dependent kinase 4
(CDK4) and cyclin D1. Their specific association with Fmrp
was further confirmed by additional IP and RT-PCR
(Figure 5B). We therefore examined the expression levels of
C D K 4a n dc y c l i nD 1i nb o t hW Ta n dFmr1 KO aNPCs.
Though there was no significant change in the mRNA levels
(Figure S6B), the loss of Fmrp led to higher protein levels of
both genes (Figure 5C, Figure S6). Both CDK4 and cyclin D1
expression levels are important for the proliferation of neural
Figure 3. Loss of Fmrp alters the proliferation of neural stem and progenitor cells in vivo. (A) Experimental scheme for assessing cell
proliferation in the adult hippocampus. Cohort 1 animals had the same injection paradigm as Figure 4 and were therefore used to assess new
cell survival. Cohort 2 animals were used to evaluate cell proliferation in the DG. (B) Examples of WT and Fmr1 KO brain sections stained with
an antibody against BrdU (red) and DAPI (blue) for in vivo neurogenesis analyses (scale bar=100 mm). (C) The dentate gyrus (DG) of Fmr1 KO
mice exhibited increased BrdU
+ cells analyzed at one day after a 7-day regimen of daily BrdU injections, suggesting increased proliferation
(Cohort 1: n=3 WT; n=4 KO). (D) At 4 hours post-BrdU injection (6 injections within 24 hours), the number of BrdU+ cells normalized to
volume of the DG was also higher in Fmr1 KO mice (p,0.05). (D–I, Cohort 2: n=7 WT; n=6 KO). (E) Fmr1 KO mice also had increased DG
volume (size) (p,0.05). (F) Single intensity projection confocal z-series showing two different types of BrdU+ cells in the DG of the
hippocampus. Upper panel, BrdU+ (red), Nestin+ (green), and GFAP2 (blue) progenitor cells; Lower panel, BrdU+ (red), Nestin+ (green), and
GFAP+ (blue) stem-like cells. (G) The DG of Fmr1 KO mice exhibited increased proliferation of progenitor (BrdU
+ Nestin
+,G F A P
2) cells analyzed
at 4 hours following 6 BrdU injections within a 24-hour period. (H) The DG of Fmr1 KO mice exhibited increased proliferation of stem (BrdU
+
Nestin
+,G F A P
+) cells analyzed at 4 hours after 6 BrdU injections within a 24-hour period. (n=7 WT; n=6 KO). Data are presented as mean 6
SEM; *, p,0.05, **, p,0.01, ***, p,0.01, Student’s t-test.
doi:10.1371/journal.pgen.1000898.g003
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of CDK4 could partially rescue the proliferation phenotype
of Fmr1 KO aNPCs (Figure S6C). Hence increased expression
of CDK4 and cyclin D1 as a result of Fmrp deficiency could be
responsible for the increased proliferation of Fmr1 KO aNPCs.
We also noticed that the mRNA of GSK3ß, known to be
involved in the Wnt signaling pathway, could be coimmunopre-
cipitated with Fmrp from aNPCs. We confirmed the specific
association between Fmrp and the mRNA of GSK3ß using
additional Fmrp IP coupled to real-time PCR (Figure 5B).
Furthermore, we confirmed that the loss of Fmrp led to increased
protein levels of GSK3b (Figure 5C) and reduced protein levels of
ß-catenin (Figure S7), a downstream target of GSK3b in
proliferating Fmr1 KO aNPCs.
Loss of Fmrp alters the activity of the Wnt signaling
pathway in adult neurogenesis
To determine whether Fmrp could regulate the translation of
GSK3b protein, we cloned the 39 untranslated region (39UTR) of
GSK3b and inserted it into the 39 region of the Renilla luciferase
coding sequence, such that the translation of Renilla luciferase
could be regulated by the 39UTR of GSK3b. Upon transfection of
Figure 4. Loss of Fmrp alters the differentiation of neural stem and progenitor cells in vivo. (A) Experimental scheme for assessing new
cell survival and differentiation in the adult hippocampus. (B,C) Sample confocal images showing newborn cells that had differentiated into NeuN
+
neurons (B, asterisk) or S100b
+ astrocytes (C, asterisk). Asterisks, but not arrowheads, indicate BrdU
+ cells that have differentiated into either a neuron
(H) or an astrocyte (E). (D) At 4 weeks post-labeling, BrdU
+ cells in the Fmr1 KO DG were no different from WT mice (n=7 WT; n=9 KO). (E) At 4 weeks
post-BrdU injection, brains were analyzed for survival of newborn cells in the DG. The ratio of BrdU
+ cells at 4 weeks post-injection (numbers used for
D) over 1 day post-injection (average of BrdU+ cells shown in Figure 3D) indicated that Fmr1 KO mice had fewer surviving newborn cells in the DG.
(F,G) Quantitative analysis indicated that newborn cells in Fmr1 KO mice differentiated into a lower percentage of neurons (F) but a higher
percentage of astrocytes (G) compared with WT mice (n=9 WT; n=9 KO). All data are shown as mean 6 SEM, and Student’s t-test was used for all the
analyses. *, p,0.05, **, p,0.01 ***, p,0.001.
doi:10.1371/journal.pgen.1000898.g004
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significantly higher Renilla luciferase activity in Fmr1 KO aNPCs
compared with WT aNPCs, suggesting that the 39UTR of GSK3ß
leads to increased translational activity in Fmr1 KO cells (Figure
S7A). To further ensure that this increased protein level was due to
increased translation rather than reduced protein stability of
GSK3b in Fmr1 KO cells, we treated Fmr1 KO and WT aNPCs
with the protein synthesis inhibitor cycloheximide over a 24-hour
period. We found that, even though the GSK3b protein level was
higher in the KO cells (time 0 h), there was no significant
difference in the rate of GSK3b protein degradation between WT
and KO aNPCs (Figure S7B). Therefore, these data suggest that
Fmrp regulates the protein translation of GSK3b.
The canonical Wnt pathway is known to be critical for adult
neurogenesis, but the downstream effectors have been a mystery
[20,26]. Since Fmrp was able to regulate the translation of
GSK3b, we further investigated whether the activity of the Wnt
pathway was altered in Fmr1 KO aNPCs. GSK3b is known to
phosphorylate and promote the proteasome degradation of ß-
catenin, a central player in the Wnt signaling pathway. We
therefore chose to examine the expression of ß-catenin in aNPCs.
In both proliferating and differentiating aNPCs, we observed
increased GSK3b protein levels (Figure 5C) and decreased
expression of ß-catenin (Figure 6A and Figure S7C). Hence Fmrp
may promote adult neurogenesis by regulating the expression of
GSK3b and subsequently ß-catenin.
In the absence of Wnt, ß-catenin is known to be held in
cytosol and degraded by a collection of regulatory factors, such
as GSK3b [27]. The activation of Frizzled by Wnt leads to
stabilization and nuclear translocation of ß-catenin, which forms
a complex with TCF/LEF transcription factors and induces the
expression of downstream target genes [27]. To confirm that
loss of Fmrp led to the deficit in the Wnt signaling pathway, we
used a well-characterized luciferase reporter system for moni-
toring the activity of the Wnt signaling pathway [26,49]. Upon
growth factor withdrawal and activation by cotransfected
Wnt3a expression vector, Fmr1 KO aNPCs exhibited signifi-
cantly reduced luciferase activity compared with WT aNPCs
(Figure 6B). In addition, expression of Axin2, a downstream
effector of the Wnt signaling pathway, was reduced in the
hippocampus of Fmr1 KO mice (Figure S8). Therefore, the Wnt
signaling pathway is indeed defective in the absence of Fmrp. In
addition, treatment of Fmr1 KO aNPCs with a well-established
GSK3b inhibitor SB216763 [50] could enhance the Wnt
Figure 5. Identification of the mRNAs regulated by Fmrp in aNPCs. (A) Western blotting shows the amount of Fmrp in both input and
immunoprecipitated Fmrp-containing mRNP complexes from both WT and Fmr1 KO aNPCs. (B) The RNAs from Input and from Fmrp-IP of WT and KO
cells were isolated and subjected to cDNA synthesis and real-time PCR quantification. The results confirmed that Fmrp binds to the mRNAs of MAP1B,
EF1a, CDK4, cyclin D1, and GSK3b in WT aNPCs. KO aNPCs and ß-Actin mRNA analyses were used as negative controls. (C) Representative western
blotting image showing the protein expression levels of the target genes of Fmrp in both WT and Fmr1 KO aNPCs. EIF5 was used as a loading control for
MAP1B, and ß-actin was used as a loading control for the others in western blots. Quantification of western blot band intensities is shown in Figure S6A.
doi:10.1371/journal.pgen.1000898.g005
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neuronal (Figure 6C and 6D) and astrocyte (Figure 6E and
6F) differentiation deficits in aNPCs. Similar results were also
obtained using the DG aNPCs (Figure S9B and S9C).
Interestingly, SB216763 also repressed aNPC proliferation
without affecting cyclin D1 expression levels (Figure S10).
Therefore, Fmrp deficiency leads to reduced Wnt signaling,
which could be responsible for altered aNPC differentiation.
Loss of Fmrp alters the expression of Neurog1 in aNPCs
The basic helix-loop-helix family transcription factor neurogenin1
(Neurog1) can be regulated by Wnt signaling, and its promoter
contains one single classic TCF/LEF binding element [51]. We
therefore assessed the mRNA levels of Neurog1 in Fmr1 KO
proliferating and differentiating aNPCs. Neurog1 was transiently
expressed in differentiating WT aNPCs (Figure 6G), as shown
previously [51]. We found that Neurog1 mRNA levels indeed
Figure 6. Loss of Fmrp leads to a deficit in the Wnt signaling pathway and reduced Neurog1 expression in aNPCs. (A) In differentiating
Fmr1 KO aNPCs (24 hours after initiation of differentiation), the GSK3b protein level was higher and b-catenin protein level was lower compared with
differentiating WT aNPCs. (B) Differentiating Fmr1 KO aNPCs have defective Wnt signaling, as indicated by the level of TCF/LEF-luciferase activity. A
mutant promoter with the TCF/LEF site mutated was used as a negative control (n=3). (C–F) The GSK3b inhibitor SB216763 (SB) could partially rescue
the reduced neuronal (C,D) and increased astrocyte (E,F) differentiation deficits of Fmr1 KO aNPCs. SB (dissolved in DMSO) was added at initiation of
differentiation at 4 mM. An equal amount of DMSO was added to WT and KO control aNPCs. Cell differentiation was assessed by the relative mRNA
levels of NeuroD1 (C), Tuj1 (D), GFAP (E), and aquporin4 (F). GAPDH mRNA levels were used as an internal control. (G) Real-time quantitative PCR results
show that early differentiating (24 hours) WT aNPCs transiently express high levels of Neurog1 (,10-fold induction compared with 0 hour; n=4). This
Neurog1 induction is drastically impaired in differentiating (24 hours) Fmr1 KO aNPCs (,26-fold; n=4). Proliferating aNPCs (0 hour), and later
differentiating (48 hours) cells, expressed a minimal level of Neurog1. Inset, similar results obtained by regular RT-PCR. (H) The Wnt receptor ligand,
Wnt3a, is required for activating the Neurog1 promoter during differentiation. In the presence of Wnt3a, Neurog1 promoter activity was significantly
lower in Fmr1 KO aNPCs compared with WT cells. Neurog1 promoter activity was undetectable in the absence of Wnt3a (n=3). (I) Exogenously
expressed wild-type Fmr1, but not mutant Fmr1, could promote the Neurog1 transcription as assessed by Neurog1 promoter activities in both Fmr1
KO and WT aNPCs (n=3). All data are shown as mean 6 SEM, and Student’s t-test was used for all the analyses. *, p,0.05, **, p,0.01***, p,0.001.
doi:10.1371/journal.pgen.1000898.g006
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determine whether the altered Neurog1 expression resulted from a
Wnt signaling deficit in Fmr1 KO aNPCs, we created a reporter
construct that has a mouse native Neurog1 promoter driving the
expression of luciferase. When transfected into Fmr1 WT and KO
aNPCs that were subjected to differentiation, the Neurog1-luciferase
reporter yielded detectable luciferase activity only in the presence of
Wnt3a (Figure 6H), indicating that this promoter is activated by
Wnt signaling. As expected, we found that Neurog1 promoter activity
was significantly reduced in differentiating Fmr1 KO aNPCs
compared with WT cells (Figure 6H). Furthermore, we could
rescue the Neurog1 promoter activity by expressing the wild-type but
not the mutant Fmr1 in Fmr1 KO aNPCs (Figure 6I). Taken
together, these data suggest that the expression of Neurog1 is
controlled by Fmrp through the Wnt signaling pathway in aNPCs.
Since Neurog1 is an early initiator of neuronal differentiation
and an inhibitor of glial differentiation [28], its downregulation
could be responsible for the reduced neuronal differentiation and
increased glial differentiation seen in Fmr1 KO aNPCs. To test this
possibility, we expressed exogenous Neurog1 in Fmr1 KO
forebrain aNPCs and found that exogenously expressed Neurog1
could rescue the altered fate specification of Fmr1 KO aNPCs, as
assessed by the mRNA levels of neuronal genes (Figure 7A,
NeuroD1 and Tuj1) and astrocytic genes (Figure 7B, GFAP and
aquqporin4), as well as the promoter activity of NeuroD1 and GFAP
(data not shown) in differentiating cells. To further validate the
role of Neurog1 in aNPC differentiation, we acutely knocked
down Neurog1 expression in aNPCs using siRNA (Figure 7C) and
found that acute knockdown of Neurog1 in aNPCs led to
decreased neuronal differentiation (Figure 7D), but increased
astrocyte differentiation (Figure 7E), reminiscent of what we found
in Fmr1 KO aNPCs. Similar results were also obtained using the
DG aNPCs (Figure S11). Therefore, our findings suggest that
Fmrp regulates aNPC fate specification by modulating the activity
of the Wnt/b-catenin signaling pathway and subsequently its
downstream effector, Neurog1 (Figure 7F).
Discussion
In this study we demonstrate that the loss of functional Fmrp in
aNPCs leads to reduced neurogenesis both in vitro and in vivo.W e
show that Fmrp regulates the translation of several factors involved
in stem cell proliferation and differentiation, including CDK4,
cyclin D1, and GSK3b. As a result of dysregulation of GSK3b and
the Wnt signaling pathway, the expression level of Neurog1, one of
the Wnt-regulated genes, is reduced, which is likely responsible for
the reduced neuronal differentiation and increased astrocyte
differentiation seen in Fmr1 KO aNPCs. Our data demonstrate
that Fmrp plays profound regulatory roles in adult neurogenesis.
Despite exhaustive efforts devoted to understanding transcrip-
tional regulation in adult neurogenesis, the role of translational
control in adult neurogenesis has gone largely unexplored; yet our
results indicate that translational control is just as important, if not
more so, in the regulation of aNPC functions. We have identified
the molecular pathways by which Fmrp regulates aNPC
proliferation and fate specification. Both a previous study from
another group [52] and our current study found that the mRNAs
of both CDK4 and cyclin D1 could be bound by Fmrp. CDK4
and cyclin D1 are well-characterized cell-cycle regulators in many
cell types [53]. In mammalian neural progenitor cells, increased
cyclin D1 expression is positively correlated with their proliferation
[54], and reduced cyclin D1 levels result in decreased proliferation
[48]. CDK4 has been shown to regulate the proliferation of neural
progenitors in adult brains [47], and inhibition of CDK4 activity
leads to growth arrest in neural progenitors [46]. The fact that we
could rescue the proliferation deficits of Fmr1 KO aNPCs using a
chemical inhibitor of CDK4 supports our model that Fmrp
regulates aNPC proliferation in part through CDK4.
We also found here that Fmrp could bind and regulate the
translation of GSK3b mRNA. As a negative regulator of the Wnt
signaling pathway, GSK3b promotes the degradation of b-catenin
and inhibits the activity of the canonical Wnt signaling pathway
[27]. The Wnt signaling pathway has been shown to promote the
proliferation of a number of cell types, including hematopoietic
stem cells [55]. Although one study suggests that Wnt signaling
can also promote cell proliferation in the DG [56], other
publications clearly point out the function of the Wnt signaling
pathway in activating neuronal differentiation during adult
neurogenesis, and inhibiting this pathway results in hippocam-
pus-dependent learning deficits [20,26,57]. Our data show Fmr1
KO aNPCs had reduced Wnt signaling, and we identified
Neurog1 as one of the downstream targets of Fmrp and Wnt.
Neurog1 is a transcription factor expressed only at the early stage
of differentiation, and it promotes neuronal differentiation while
inhibiting astrocyte differentiation [28,29]. Neurog1 contains a
conserved Tcf/Lef binging site in its promoter, allowing it to sense
the levels of Wnt signaling. Although the Wnt signaling pathway
has been found to enhance cyclin D1 transcription in HeLa cells
and several other cell types [58], we saw no such activation in
aNPCs. Interestingly, enhancing Wnt signaling via a Gsk3b
inhibitor repressed proliferation of Fmr1 KO aNPCs, possibly due
to the neuronal differentiation effect of Wnt signaling. It is likely
that in aNPCs, Wnt signaling and cyclin D1 act independently on
cell proliferation, and they are both also regulated by Fmrp.
Several studies have examined embryonic and early postnatal
neurogenesis in mice [25] and humans [24]. One study found that
the loss of Fmrp led to increased neuronal differentiation and
reduced glial differentiation in mice [25]. Due to the large scale of
embryonic neurogenesis, factors affecting aNPCs would also be
expected to affect both the overall number of neurons, as well as
brain size. However, neither adult fragile X patients nor adult
Fmr1 KO mice show any differences in the number of neurons and
glia compared with controls [59], raising questions about the
potential significance of increased early neurogenesis to the
pathogenesis of fragile X syndrome. Another study found no
alteration in the differentiation of embryonic NPCs (eNPCs)
isolated from one human embryo diagnosed with a fragile X
mutation [24]. While the discrepancies between human and
mouse studies require further confirmation using additional
human tissues, the different phenotypes observed in Fmrp-
deficient eNPCs versus aNPCs support the idea that adult
neurogenesis is subjected to regulatory mechanisms distinct from
those in embryonic neurogenesis [22]. First, during adult
neurogenesis, multipotent aNPCs are in intimate contact with
the surrounding mature neurons and glia, and the fate of aNPCs
can be affected by their microenvironment [8,9,22,60]. Mice that
lack Sonic hedgehog [61], Tlx [62], Bmi1 [63,64], and Mbd1 [33]
have all exhibited profound deficits in postnatal neurogenesis, but
not in their embryonic neural development. In fact, in prenatal
and early postnatal developing brains, Fmrp is widely expressed in
neural cells, including glia and glial precursors, with the levels of
Fmrp decreasing during oligodendrocyte differentiation [65,66],
whereas in adult brains, Fmrp is expressed predominantly in
neurons, with negligible expression in mature glia [30,31]. Further
studies into the role of Fmrp in both embryonic and adult
neurogenesis would facilitate our understanding of the unique
molecular networks that regulate eNPCs and aNPCs at the level of
translational control.
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campus-dependent learning [8,9], and blocking neurogenesis using
methods nonexclusive to adult NPCs or new neurons has
supported this model [14–17,20]. Altered adult hippocampal
neurogenesis and impaired learning have been found in several
pathological conditions [9,21]; however, the possibility of a link
between adult neurogenesis and human mental retardation
disorders, though recently put forward [67], has not been studied
well. Although there is a low level of DG neurogenesis in adults,
mounting evidence points to its potentially important role in
neuroplasticity, emotional behavior, and the higher cognitive
functions of adult brains. It has been proposed that adult
neurogenesis enables the lifelong adaptation of the hippocampal
network to the levels of novelty and complexity a person
Figure 7. Neurog1 regulates the fate specification of aNPCs. (A,B) Exogenously expressed Neurog1 could rescue the neuronal and astrocyte
differentiation deficits of Fmr1 KO aNPCs, as assessed by real-time PCR of neuron (NeuroD1 and Tuj1) and astrocyte (GFAP and aquaporin4)-specific
gene expression (n=3; Control, pCDNA3 empty vector) (C) Neurog1-siRNA could specifically reduce the Neurog1 protein expression from a co-
transfected Neurog1 expression vector. siRNA-2 was more effective at reducing Neurog1 protein expression, and was therefore used in all functional
tests. NC-siRNA: Nonsilencing Control siRNA. (D,E) Acute knockdown of Neurog1 expression in aNPCs led to reduced neuronal differentiation (D), but
increased astrocyte differentiation (E) in WT aNPCs, as assessed by real-time PCR of cell lineage-specific genes (n=3). Cell differentiation was assessed
by the relative mRNA levels of NeuroD1 (A and D, left), Tuj1 (A and D, right), GFAP (B and E, left), and aquporin4 (B and E, right). GAPDH mRNA levels
were used as an internal control for all real-time PCR analyses, unless stated otherwise. (F) Model of Fmrp functions in adult neurogenesis. By
regulating the translation of cyclin D1 and CDK4, Fmrp controls the proliferation of aNPCs. By controlling the translation of GSK3b, Fmrp maintains
the proper intracellular levels of b-catenin and Wnt signaling. Upon differentiation, b-catenin positively regulates the expression of Neurog1, which
promotes neuronal differentiation and represses glial differentiation. All data are shown as mean 6 SEM, and Student’s t-test was used for all the
analyses. *, p,0.05; ***, p,0.001.
doi:10.1371/journal.pgen.1000898.g007
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methods coupled with confocal microscopy, we observed a mild
but significant reduction in the number of new neurons in Fmr1
KO mice, which could easily have been missed by others who
employed non-stereology quantification methods [68]. Due to the
restricted nature and low level of adult neurogenesis, a lack of
Fmrp may not affect the total number of neurons in adult brains,
but it can contribute to pathological conditions linked to higher
cognitive functions and learning abilities [9,67]. The learning
deficits of the Fmr1 KO mice may be the result of both reduced
neurogenesis and defective neuronal maturation. Consistent with
the literature [69], we have observed that Fmr1 KO aNPC-
differentiated neurons had reduced dendritic complexity and
length (data not shown), which could also contribute to behavioral
deficits. In addition, although Fmr1 KO mice have increased
proliferation, at four weeks post-BrdU labeling, both KO and WT
mice had similar numbers of surviving new cells, possibly due to
the decreased survival of new cells in KO mice. How Fmrp
regulates the survival of young neurons is another interesting
question that is currently being pursued as an independent study.
One mystery that remains to be cleared up is why the size of the
DG in the adult Fmr1 KO mice is bigger than in controls. Since
the new cells generated in the adult DG account for only a small
portion of the total DG cells, increased proliferation of these new
cells may not contribute much to the increased size of the DG.
Castren et al. [25] have shown that Fmr1 KO mice exhibit
increased cell proliferation in the subventricular zone during
embryonic development (E13). The mammalian DG is formed
during the postnatal period, with P7 as the peak of cell genesis. It is
possible that increased cell proliferation during DG formation
results in an increased DG volume that persists into adulthood. In
addition to its function in the initial stage of neurogenesis, Fmrp-
deficient neurons are known to have reduced dendritic complexity
[25,70]; therefore, it is possible that new neurons generated in the
adult DG also have reduced dendritic complexity. Hence deficits
in several stages of adult neurogenesis could contribute to the
higher brain functions, such as the learning and emotional
disabilities associated with fragile X patients, without significantly
affecting the gross brain structure of human patients.
Our results suggest that translational regulation by Fmrp in
aNPCs and young neurons is essential for learning and memory,
and the reduced number of new neurons together with defective
maturation of these new neurons may contribute to the cognitive
deficiency seen in fragile X patients. This is a facet of the etiology
of fragile X syndrome that has not been recognized before.
Materials and Methods
Fmr1 KO mice
All animal procedures were performed according to protocols
approved by the University of New Mexico Animal Care and Use
Committee. The Fmr1 KO mice bred onto the C57B/L6 genetic
background were as described previously [71].
Isolation and cultivation of adult NPCs
Adult aNPCs used in this study were isolated from 8- to 10-
week-old male Fmr1 KO mice and wild-type (WT) controls based
on published methods: for the forebrain aNPCs [33] and for the
DG aNPCs [72]. (See Text S1 for details.)
Proliferation, differentiation, cell death analyses, and
chemical treatment of cultured aNPCs
These analyses were carried out using our established method
[32,34]. (See Text S1 for details.)
In vivo neurogenesis studies
In vivo neurogenesis analyses were performed essentially as
described previously [32,33]. These experiments have been
performed using 3 different batches of animals, with n=4–6/
genotype each batch. For the first two batches, BrdU (50mg/kg)
was injected into 8-week-old mice daily for 7 consecutive days to
increase the amount of labeling. Mice were then euthanized 1 day
post-injection to assess the in vivo proliferation (and early survival)
of labeled cells. For cell survival analysis, another group of mice
was injected with BrdU at 8 weeks of age and euthanized 4 weeks
post-injection. The third batch of mice, on the other hand, were
given 6 injections of BrdU (50 mg/kg) within 24 hours to label all
dividing cells in the DG within this time period and sacrificed at
4 hours post-last injection based on a published protocol [41].
Mice were euthanized by intraperitoneal injection of sodium
pentobarbital, and then transcardially perfused with saline
followed by 4% PFA. Brains were dissected out, post-fixed
overnight in 4% PFA, and then equilibrated in 30% sucrose.
Forty-mm brain sections were generated using a sliding microtone
and stored in a 220uC freezer as floating sections in 96-well plates
filled with cryoprotectant solution (glycerol, ethylene glycol, and
0.1 M phosphate buffer, pH 7.4, 1:1:2 by volume). We performed
immunohistological analysis on 1-in-6 serial floating brain sections
(240 mm apart) based on the published method [33]. (Please see
Text S1 for more details.)
DNA plasmids
The DNA plasmids carrying 2.5 kb of glial fibrillary acidic
protein (GFAP) promoter-firefly luciferase reporter gene (GF1L-
pGL3) or its mutant version, with the STAT3 binding site
mutated (GF1L-S-pGL3), and an internal control plasmid
containing sea pansy luciferase driven by human elongation
factor 1a promoter (EF1a-Luc) were as described previously
[34,73]. NeuroD1-luciferase, a gift from Dr. F.H. Gage, was then
cloned into pGL3 plasmid. Fmr1-siRNA, control-siRNA, and
mouse Neurog1 expression vector were purchased from Open
Biosystems (www.openbiosystems.com). Neurog1 siRNA was
purchased from SABiosciences (Frederick, MD). Wild-type Wnt
reporter construct pTOPFLASH containing 8 TCF/LEF binding
sites and mutant reporter construct pFOPFLASH were gifts from
R.T. Moon (University of Washington) as described [26]. Wnt3a
expression plasmid was a gift from Dr. D.C. Lie (Institute of
Developmental Genetics, Germany) as described [26]. Wild-type
FLAG-Fmrp was cloned into pDEST-27 vector, and mutant
FLAG-I304N was generated by site-directed mutagenesis (Stra-
tagene) [40]. All the constructs were verified by DNA sequencing.
Myelin basic protein (MBP) promoter was cloned from mouse
genomic DNA based on published information [74] and cloned
into pGL3 plasmid. The mouse Neurog1 promoter, containing its
native TCF/LEF binding site ‘‘cctttgaa,’’ was cloned by PCR
based on the GenBank sequence (GenBank ID #18014) using the
following primers: 59-GTCTGACTCTGAAGCCATCTCTGA-
39 (forward) and 59 -ACGCGCCGGGCTGGTCTCCT-39
(reverse). The PCR product was then subcloned into the
pCRII-TOPO plasmid, sequenced, and inserted into the KpnI-
XhoI site of the pGL2 basic vector to yield Neurog1-luciferase
reporter construct. The full-length 39-UTR of GSK-3ß mRNA
was PCR-amplified directly from proliferating aNPC first-strand
cDNA generated from 5 mgT R I ZOL-isolated total RNA using
oligo-dT SuperScript III reverse transcription according to the
manufacturer’s protocol (Invitrogen, Cat. #1808-093). It was
cloned into pIS2 Renilla luciferase vector, and pIS0 firefly
luciferase was used as a transfection control [75].
FMRP in Adult Neurogenesis
PLoS Genetics | www.plosgenetics.org 11 April 2010 | Volume 6 | Issue 4 | e1000898Electroporation, transfection, and luciferase assay
Electroporation of plasmid DNA into aNPCs and the luciferase
assay were carried out using an Amaxa Nucleofector electro-
porator based on the manufacturer’s protocol (Amaxa, #VPG-
1004) with modifications [34]. Briefly, 2610
6 cells were
trypsinized, resuspended in Nucleofector solution, mixed with
DNA, and electroporated using a preset program for mouse
NPCs (#A033). The cells were then plated onto polyornithin/
laminin-coated 24-well plates in proliferation medium. After
24 h, cells were changed into differentiation medium for 48 h.
Transfection of aNPCs was carried out using Stemfect (Stemgent,
San Diego, CA) based on the manufacturer’s protocol with
modifications. Briefly, aNPCs were plated into 24-well P/L-
coated plate for 24 hours. Then 3 mg DNA and 0.9 ml Stemgent
reagent were mixed, incubated for 10 minutes, and then added to
the cells. Sixteen hours later, the transfected cells were changed
into differentiation medium for 48 hours. The cells were then
collected and luciferase activity was detected using the Dual-
Luciferase Reporter 1000 System (Promega, Cat# E1980) based
on the manufacturer’s protocol. Briefly, collected cells were lysed
in 100 mlo f1 6 passive lysis buffer at room temperature for
15 minutes. Then 20 mL of the lysate was added to 100 mlo f
Luciferase Assay Buffer II and mixed briefly. Firefly luciferase (F-
luc) activity was immediately read using a SpectraMax M2E plate
reader (Molecular Devices Corp.). Next, 100 mlo fS t o p&G l o
Buffer with Stop & Glo substrate was added and mixed briefly.
Renilla luciferase (R-luc) activity was immediately read. F-luc
activity was normalized to R-luc activity to account for variation
in transfection efficiencies. Each experiment was independently
repeated 3 times. For each electroporation, 3 mg( NeuroD12 or
GFAP2) luciferase DNA, 5 mg Neurog1-luciferase DNA, 0.2 mgR -
Luc, and 0.004–2 mg Fmr1, Neurog1, or control expression
plasmids were used.
RNA immunoprecipitation, microarray assay, and real-
time PCR
These procedures were carried out as described [43]. (Please see
Text S1 for details.)
Western blots
Twenty-mg protein samples were separated on SDS-PAGE gels
and then transferred to PVDF membranes (Millipore). Mem-
branes were processed following the ECL western blotting
protocol (GE Healthcare). anti-MAP1B (a gift from I. Fischer,
Drexel University, Philadelphia), anti-Nestin (Millipore), anti-
Fmrp (7G1-1), anti-Fmrp (John Louis), anti-b-catenin (Millipore),
anti-CDK4 (Millipore), anti-Cyclin D1 (Upstate), anti-TCF4
(Abcam), GSK3ß (Abcam), anti-EF1a (ATCC), anti-Neurog1
(Millipore), anti-NeuroD1 (Santa Cruz), anti-Axin2 (Cell Signal-
ing) and anti-b-Actin (Abcam) were used as primary antibodies at
the concentrations recommended by the manufacturers. HRP-
conjugated secondary antibodies were obtained from Sigma. For
loading controls, membranes were stripped and reprobed with the
antibody against eIF5a (Santa Cruz Biotechnology), anti-GAPDH
(Ambion), or eIF4E (Transduction Laboratories). To test the
efficiency of Fmr1-siRNA, Fmrp expression plasmid and siRNA
expression plasmid were cotransfected into HEK293 cells, and the
mRNA and protein expression levels of Fmrp were analyzed using
PCR and western blot, respectively.
Statistical analysis
Statistical analysis was performed using ANOVA and Student’s
t-test, unless specified with the aid of SPSS v.17. All data were
shown as mean with standard error of mean (mean 6 SEM).
Probabilities of P,0.05 were considered significant.
Supporting Information
Figure S1 Fmrp is expressed in DG neurons but not astrocytes
in the adult hippocampus. (A) Fmrp staining is prominent in the
majority of the DG cells of WT mice but is absent in the KO mice.
(B,C) Fmrp expression was nearly undetectable in GFAP (B) or
S100b (C) expressing astrocytes. Arrows point to astrocyte that are
negative for Fmrp staining. Scale bars=10 mm.
Found at: doi:10.1371/journal.pgen.1000898.s001 (1.47 MB PDF)
Figure S2 Adult brain-derived aNPCs from Fmr1 KO mice
exhibited altered proliferation. (A) Single plain Laser Scanning
Confocal image showing that adult brain-derived aNPCs cultured
under proliferating conditions expressed neural progenitor mark-
ers: Nestin (cytoplasmic, red) and Sox2 (nuclear, green). Dapi was
used to label nuclear DNA (blue). (B–E) Cell cycle profile of WT
and Fmr1 KO aNPCs indicating that Fmr1 KO aNPCs had more
cells in mitosis (G2/M phase) and fewer cells in S phase. N=3
independent cell preparations. *, p,0.05, Student’s t-test. Data is
shown as mean 6 SEM.
Found at: doi:10.1371/journal.pgen.1000898.s002 (0.09 MB PDF)
Figure S3 Fmr1-siRNA could specifically reduce the mRNA
and protein expression of Fmrp as shown by real-time PCR (A)
and Western blotting (B).
Found at: doi:10.1371/journal.pgen.1000898.s003 (0.04 MB PDF)
Figure S4 aNPCs isolated from the DG of Fmr1 KO mice had
similar phenotypes as those found in aNPCs isolated from the
Fm1 KO forebrain. (A,B) Fmr1 KO DG aNPCs exhibited lower
NeuroD1 promoter (A) but higher GFAP promoter (B) activities.
(C,D) Fmr1 KO DG aNPCs had lower levels of endogenous
NeuroD1 mRNA (C) but higher levels of endogenous GFAP
mRNA (D). (E–H) Acute knockdown of Fmrp expression in
WT DG aNPCs using siRNA led to decreased neuronal
promoter activity (E; mean 6 SEM n=6, p,0.05) and
decreased NeuroD1 mRNA levels (F), but increased GFAP
promoter activity (G; mean 6 SEM n=6, p,0.05) and
increased GFAP mRNA levels (H; p,0.001). Therefore, Fmrp
has similar functions in DG aNPCs compared to aNPCs
derived from the forebrain. All data are shown as mean 6
SEM. Statistics was done using two tailed unpaired Student’s
t-test. *, p,0.05; **, p,0.01; ***, p,0.001. NC-siRNA,
nonsilencing control siRNA.
Found at: doi:10.1371/journal.pgen.1000898.s004 (0.10 MB PDF)
Figure S5 Reduced expression of NeuroD1 and Neurogenin1 in
Fmr1 KO mice (A,B). The protein levels of two transcription
factors specific to young neurons, NeuroD1 (A) and Neurog1 (B),
exhibited lowered expression levels in Fmr1 KO hippocampus, as
assessed by Western blot analysis. Sample images of Western blots
are shown in the upper panels and quantification of 3 blots are
shown in the lower panels. b-actin was used as a loading control.
(C) Immuno histological staining using shows reduced number of
NeuroD1-positive Cells (white arrows) in the subgranular zone of
the DG. All data are shown as mean 6 SEM. Statistics were done
using two tailed unpaired Student’s t-test. *,p,0.05; Scale
bar=10 mm.
Found at: doi:10.1371/journal.pgen.1000898.s005 (0.38 MB PDF)
Figure S6 Expression analysis of proliferating Fmr1 KO aNPCs.
(A) Quantification of Western blot band intensities (as shown in
Figure 4C) normalized to ß-actin levels demonstrates increased
protein levels of EF1a, CyclinD1, CDK4, GSK3b, and MAP1b in
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measurements with KO levels normalized to the WT levels.
Student’s t-test was performed on data before normalization to
ensure accurate statistical analysis. (B) The mRNA levels of EF1a,
CyclinD1, CDK4, GSK3b, and MAP1b were not changed in
proliferating Fmr1 KO aNPCs. The steady-state mRNA level
determined by real-time PCR was normalized to18S. (C) CDK4
inhibitor was dissolved in DMSO (0 concentration). At 60 nM,
this inhibitor can reverse the proliferation of Fmr1 KO aNPCs and
bring it to the level of WT cells (n=3), suggesting that increased
CDK4 activity might be a reason for increased proliferation of
Fmr1 KO aNPCs. Proliferation was assessed by BrdU pulse
labeling followed by immunostaining and stereological quantifica-
tion. All data are shown as mean 6 SEM. Statistics were done
using two tailed unpaired Student’s t-test. *, p,0.05.
Found at: doi:10.1371/journal.pgen.1000898.s006 (0.14 MB PDF)
Figure S7 Fmrp regulates translation of GSK3b. (A) A GSK3b
39untranslated region (39UTR) was cloned into a Renilla luciferase
(R-luc) expression vector (top panel) therefore the translation of R-
luc was regulated by the 39UTR of GSK3b. Transfection of this
construct into aNPCs resulted in higher R-Luc activity (normal-
ized to firefly luciferase internal control) in Fmr1 KO compared
with WT cells (Data is shown as mean 6 SEM; n=3, p,0.001,
Student’s t-test), suggesting that elevated translational activity is
directed by GSK3b 39UTR in the absence of Fmrp. Data is shown
as mean 6 SEM. Statistics were done using two tailed unpaired
Student’s t-test. ***, p,0.001. (B) aNPCs were treated with a
protein synthesis inhibitor, cycloheximide, during a 24 hour
period. Gsk3b protein levels were determined using Western blot
(top panel) and quantified. The result indicates that the
degradation rate of GSK3b protein is not significantly different
between Fmr1 KO and WT aNPCs. (C) b-catenin protein
expression was decreased in proliferating Fmr1 KO aNPCs. PDF
(35KB)
Found at: doi:10.1371/journal.pgen.1000898.s007 (0.13 MB PDF)
Figure S8 Reduced expression of Axin2 protein in the
hippocampus of Fmr1 KO mice The protein levels of Axin2, a
downstream effecter of canonical Wnt signaling pathway,
exhibited lowered expression levels in Fmr1 KO hippocampus.
Sample images of Western blots (left) and quantification of 3 blots
(right) are shown. b-actin was used as a loading control. Data is
shown as mean 6 SEM. Statistics were done using two tailed
unpaired Student’s t-test. *, p,0.05.
Found at: doi:10.1371/journal.pgen.1000898.s008 (0.04 MB PDF)
Figure S9 Gsk3b inhibitor could rescue the neuronal and
astrocyte differentiation deficits of Fmr1 KO DG aNPCs. (A)
Gsk3b inhibitor SB216763 (SB) SB could enhance the Wnt
signaling in both WT and Fmr1 KO aNPCs. (B,C) SB could rescue
the reduced NeuroD1 (A) mRNA levels and increased GFAP mRNA
levels (B) in Fmr1 KO aNPCs. SB (dissolved in DMSO) was added
at initiation of differentiation at 4 mM. Equal amount of DMSO
was added to WT and KO control aNPCs. All data are shown as
mean 6 SEM. Statistics were done using two tailed unpaired
Student’s t-test. *, p,0.05; **, p,0.01; ***, p,0.001.
Found at: doi:10.1371/journal.pgen.1000898.s009 (0.05 MB PDF)
Figure S10 Gsk3b inhibitor could reverse the proliferation
deficit of Fmr1 KO aNPCs. (A) Gsk3b inhibitor SB216763 (SB) SB
could repress proliferation of Fmr1 KO aNPCs. Effect on WT cells
was not statistically significant (p=0.08). (B) SB treatment did not
affect cyclin D1 expression levels in either WT or KO aNPCs
(n=3). All data are shown as mean 6 SEM. Statistics were done
using two tailed unpaired Student’s t-test. *, p,0.05; **, p,0.01.
PDF (53KB)
Found at: doi:10.1371/journal.pgen.1000898.s010 (0.13 MB PDF)
Figure S11 Neurog1 regulates the fate specification of the DG
aNPCs. Neurog1 could rescue the neuronal (A) and astrocyte (B)
differentiation deficits of Fmr1 KO DG aNPCs. Acute knockdown
of Neurog1 in WT DG aNPCs led to reduced neuronal (C) but
increased astrocyte (E) differentiation. NeuroD1 is an neuronal
lineage marker. GFAP is an astrocyte lineage marker. The relative
mRNA levels were in comparison with GAPDH mRNA.
Promoter activities of NeuroD1 and GFAP (fire fly luciferase, luc)
were normalized to a cotransfected internal control (E1a-Renilla
luciferase, Rluc). All data are shown as mean 6 SEM. Statistics
were done using two tailed unpaired Student’s t-test. *, p,0.05;
**, p,0.01; ***, p,0.001.
Found at: doi:10.1371/journal.pgen.1000898.s011 (0.10 MB PDF)
Text S1 Supplemental methods.
Found at: doi:10.1371/journal.pgen.1000898.s012 (0.13 MB PDF)
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